Subunit engineering enables the generation of human interleukin-39 as a proinflammatory cytokine
Science Signaling · 03.11.2026 · 19 (962)
DOI: 10.1126/scisignal.adw9746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 03.11.2026. Verfasst von Chantal J Bergmann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Functional Protein Assemblies (CPA), Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Garching, G…. Hauptthemen laut MEDLINE: Protein Engineering, Interleukins, Cytokines. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Casanuswerk KH.
Abstract (Originalsprache)
Interleukins are signaling proteins that control immune responses. Defining the range of human interleukins, their associated receptors, signaling pathways, and functions is thus indispensable for understanding and modulating protective and pathological immunity. Interleukin-39 (IL-39), a heterodimer composed of the subunits IL-23α and EBI3, has been described as a proinflammatory cytokine in mice, but its existence in the human interleukin repertoire has remained controversial. Here, we showed that IL-39 did not readily form from IL-23α and EBI3 in human cells. A combined computer modeling and experimental approach identified structural features that destabilize the human IL-23α:EBI3 heterodimer. Using these insights, we rationally engineered human IL-23α and EBI3 to form disulfide-linked heterodimers that were secreted by cells. This engineered cytokine engaged the receptor subunits IL-23R and gp130 on primary human immune cells to stimulate phosphorylation of the transcriptional regulators STAT1 and STAT3, resulting in proinflammatory cytokine secretion. Together, our findings define limitations in the biogenesis of human IL-39 and show that these can be overcome by molecular engineering. This work highlights the potential of rational cytokine engineering for generating active immune signaling proteins and lays the foundation for further defining possible roles of IL-39 in human immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Functional Protein Assemblies (CPA), Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany.
- Cancer and Immunometabolism Research Group, Gene Center, Ludwig-Maximilians-Universität München, Munich, Germany.
- Department of Medicine III, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
- German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.
- Center for Translational Cancer Research (TranslaTUM), Technical University of Munich, Munich, Germany.
ORCID-Profile: Chantal J Bergmann, Carla K Ambrosius, Jonathan Held, Rosa J Weidenspointner, Nathalie Haft, Karen Hildenbrand, Sebastian Theurich, Martin Zacharias, Matthias J Feige
Förderung
- Deutsche Forschungsgemeinschaft
- Casanuswerk KH
Zitieren
APA
Bergmann, C. J., Ambrosius, C. K., Hadzic, A., Kerle, A., Held, J., Weidenspointner, R. J., Haft, N., Hildenbrand, K., Theurich, S., Zacharias, M., & Feige, M. J. (2026). Subunit engineering enables the generation of human interleukin-39 as a proinflammatory cytokine. Science Signaling, 19(962). https://doi.org/10.1126/scisignal.adw9746
Vancouver
Bergmann CJ, Ambrosius CK, Hadzic A, Kerle A, Held J, Weidenspointner RJ, et al. Subunit engineering enables the generation of human interleukin-39 as a proinflammatory cytokine. Science Signaling. 2026;19(962). doi:10.1126/scisignal.adw9746
BibTeX
@article{Bergmann2026,
author = {Bergmann, Chantal J and Ambrosius, Carla K and Hadzic, Amar and Kerle, Anna and Held, Jonathan and Weidenspointner, Rosa J and Haft, Nathalie and Hildenbrand, Karen and Theurich, Sebastian and Zacharias, Martin and Feige, Matthias J},
title = {Subunit engineering enables the generation of human interleukin-39 as a proinflammatory cytokine},
journal = {Science Signaling},
year = {2026},
volume = {19},
number = {962},
doi = {10.1126/scisignal.adw9746}
}
EUVIMED